Sanofi in discussions to sell a controlling stake in Opella Paris, . Sanofi today announces that the company has entered into negotiations with CD&R for the potential sale of ...

Les résultats du troisième trimestre 2024 seront commentés par le management au cours d'un webcast audio en direct avec la communauté financière. La présentation sera suivie d'une session de questions ...

Communiqué de presse : Approbation du Sarclisa aux États-Unis : premier anti-CD38, en association avec un traitement conventionnel, pour les patients atteints d ...

New Beyfortus data featured at IDWeek reinforce real-world effectiveness against RSV disease and hospitalization in infants Paris, . Sanofi advances its ambition to protect ...

Cliacil 1.200.000 IU film tablet - Kisa ürün bi̇lgi̇si̇ ...

Veuillez compléter ce formulaire pour communiquer avec Sanofi Canada. Tous les renseignements que vous fournissez seront conservés en conformité avec notre politique de confidentialité. Nous ...

이전에 2차 이상의 전신 요법에 실패한 만성 이식편대숙주 질환이 있는 성인 및 12세 이상의 소아 환자의 치료 ...

Third quarter 2024 results will be reviewed by management during a live audio webcast with the financial community. The presentation will be followed by a Q&A session. Third quarter 2025 results will ...

Sanofi’s commitment to society is long-term, and a longstanding legacy. Our commitment translates into a set of actions to make a positive impact on the lives of people and communities around the ...

Paris, France – September 26, 2024. Sanofi announced today that its Q3 2024 Aide mémoire is available on the "Investors" page of the company's website: As for each quarter, Sanofi prepared this ...

Samarbete mellan industri och vårdpersonal gynnar patienterna. Det är en relation som har resulterat i många innovativa mediciner och som har förändrat hur flertalet sjukdomar påverkar våra liv. 1 ...

100% of developing countries work towards the UNFCCC goal of having their NAPs in place by 2025, with all new NAPs including specific health targets reflecting national and sub-national priorities.